Barclays »

Zenas Biopharma shares owned by Barclays

Quarter-by-quarter ownership of Zenas Biopharma shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $262k 16k 16.90

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Opt Put Option (QQQ)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple Opt Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Tesla Opt Put Option (TSLA)
Ishares Tr Fund (HYG)
Facebook Inc cl a (META)
Berkshire Hathaway (BRK.B)
Broadcom (AVGO)
Visa (V)
Alphabet Opt Put Option (GOOG)

View all positions for Barclays

Top funds holding Zenas Biopharma

NEA Management Company
Fairmount Funds Management
NVP Associates
Deerfield Management Company
Federated Investors
Novo A/S
Perceptive Advisors
Pivotal bioVenture Partners Investment Advisor
T. Rowe Price Associates
Arrowpoint Asset Management
Monashee Investment Management
Citadel Advisors
Standard Life Aberdeen
Point72 Asset Management
Soros Fund Management

View all funds holding Zenas Biopharma